CHF Solutions, Inc. To Announce Fourth Quarter 2020 Financial Results on March 2, 2021

Rhea-AI Summary

CHF Solutions, Inc. (NASDAQ: CHFS) will release its fourth quarter 2020 financial results on March 2, 2021. A conference call and webcast will be held at 9:00 AM ET to discuss these results and provide a business overview. Investors can access the live webcast through the company's Investors page or by calling directly using provided numbers. CHF Solutions focuses on developing the Aquadex SmartFlow™ system for ultrafiltration therapy for patients with fluid overload, operating globally with subsidiaries in Australia and Ireland.

Positive

• Upcoming release of fourth quarter 2020 financial results provides transparency.
• Conference call offers direct communication with management for investors.

Negative

• None.

EDEN PRAIRIE, Minn., Feb. 16, 2021 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ: CHFS) announces today that its fourth quarter 2020 financial results will be released on Tuesday, March 2, 2021. The company will host a conference call and webcast at 9:00 AM ET that morning, during which management will discuss the company's financial results and provide a general business overview.

To access the live webcast, please visit the Investors page of the CHF Solutions website at http://ir.chf-solutions.com or access the webcast directly at http://ir.chf-solutions.com/events. Alternatively, you may access the live conference call by dialing (877) 303-9826 (U.S.) or (224) 357-2194 (international) and using conference ID: 5495878. An audio archive of the webcast will be available following the call on the Investor page at http://ir.chf-solutions.com/events.

About CHF Solutions

CHF Solutions, Inc. (Nasdaq: CHFS) is a medical device company dedicated to changing the lives of patients suffering from fluid overload through science, collaboration, and innovation. The company is focused on developing, manufacturing and commercializing the Aquadex SmartFlow™ system for ultrafiltration therapy. CHF Solutions is headquartered in Minneapolis, Minn., with wholly-owned subsidiaries in Australia and Ireland. The company has been listed on the Nasdaq Capital Market since February 2012.

FAQ

When is CHF Solutions' fourth quarter 2020 financial results announcement?

CHF Solutions will announce its fourth quarter 2020 financial results on March 2, 2021.

How can I access CHF Solutions' conference call for Q4 2020 results?

The conference call can be accessed by dialing (877) 303-9826 in the U.S. or (224) 357-2194 internationally, using conference ID: 5495878.

What is the focus of CHF Solutions as a medical device company?

CHF Solutions is focused on developing and commercializing the Aquadex SmartFlow™ system for ultrafiltration therapy to treat fluid overload.

Where is CHF Solutions headquartered?

CHF Solutions is headquartered in Minneapolis, Minnesota.